Ashwani Gujral, Fund manager at ashwanigujral.com told CNBC-TV18, "Above 8,000, all kinds of momentum stocks, midcaps, everything starts to fire. So, now broader market participation will be much greater. So, Aurobindo Pharma appears to have made some sort of a bottom. So, these are good levels to get into it. The stock is a buy with a stop loss of Rs 760 and target of Rs 795.""Reliance Infrastructure is a buy with a stop loss of Rs 545, target of Rs 570 and Reliance Capital is a buy with a stop loss of Rs 417 and target of Rs 440," he said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!